id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-4166-0001,FDA,FDA-2015-N-4166,Public Meeting on Patient-Focused Drug Development for Psoriasis,Notice,Meeting,2015-11-25T05:00:00Z,2015,11,2015-11-25T05:00:00Z,2016-05-18T03:59:59Z,2016-05-18T04:00:33Z,2015-29992,0,0,0900006481d724c6